Global Innovative Platforms (GIPL) Cash from Financing Activities (2020 - 2026)
Global Innovative Platforms' (GIPL) quarterly Cash from Financing Activities came in at $105646.0 in Q2 2026, down 53.36% year-over-year from $226501.0 in Q2 2025, and down 78.69% quarter-over-quarter from $495854.0 in Q1 2026.
Powered by 
Analysis
Global Innovative Platforms (GIPL) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Global Innovative Platforms has disclosed Cash from Financing Activities across 7 years of filings, most recently posting $105646.0 for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 53.36% year-over-year to $105646.0; the TTM figure through Jun 2026 stood at $680000.0 (down 8.55% YoY), while the FY2025 annual figure was $754001.0, up 766.89% from the prior year.
- Cash from Financing Activities came in at $105646.0 for Q2 2026 at Global Innovative Platforms, down from $495854.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $495854.0 in Q1 2026 to a low of $147.0 in Q1 2023.
- Average Cash from Financing Activities over 5 years is $102914.4, with a median of $60000.0 recorded in 2025.
- The largest YoY upside for Cash from Financing Activities was 11966.6% in 2025 against a maximum downside of 93.54% in 2025.
- Over 5 years, Cash from Financing Activities stood at $99853.0 in 2022, then slumped by 74.06% to $25906.0 in 2023, then jumped by 1005.93% to $286501.0 in 2024, then sank by 93.54% to $18500.0 in 2025, then jumped by 471.06% to $105646.0 in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were $105646.0 in Q2 2026, $495854.0 in Q1 2026, and $18500.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | -325.19 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -813.00 Mn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | -74.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -1.62 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 105,646.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 105,646.00 |
| Mar 31, 2026 | 495,854.00 |
| Dec 31, 2025 | 18,500.00 |
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 226,501.00 |
| Mar 31, 2025 | 180,999.00 |
| Dec 31, 2024 | 286,501.00 |
| Sep 30, 2024 | 49,582.00 |
| Jun 30, 2024 | 9,990.00 |
| Mar 31, 2024 | 1,500.00 |
| Dec 31, 2023 | 25,906.00 |
| Sep 30, 2023 | 76,398.00 |
| Jun 30, 2023 | 11,053.00 |
| Mar 31, 2023 | 147.00 |
| Dec 31, 2022 | 99,853.00 |
| Sep 30, 2022 | 89,615.00 |
| Jun 30, 2022 | 11,500.00 |
| Sep 30, 2021 | -18,500.00 |
| Jun 30, 2021 | -32,504.00 |
| Mar 31, 2021 | 39,951.00 |